Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy

The present disclosure describes the use of sodium channel blockers such as tetrodotoxin or saxitoxin, its analogs/derivatives as well as their acceptable salts, for treating neuropathic pain resulting from chemotherapy. Methods, compositions, dose units and dose forms of tetrodotoxin related to the...

Full description

Saved in:
Bibliographic Details
Main Authors Lu, Susan, Korz, Walter, Wong, Donald, Baeyens, Jose Manuel, Hernandez, Jose Miguel Vela, Buschmann, Helmut Heinrich
Format Patent
LanguageEnglish
Published 11.12.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure describes the use of sodium channel blockers such as tetrodotoxin or saxitoxin, its analogs/derivatives as well as their acceptable salts, for treating neuropathic pain resulting from chemotherapy. Methods, compositions, dose units and dose forms of tetrodotoxin related to the use are described.
Bibliography:Application Number: US201615268378